This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harashima, N. Articles by Kannagi, M. Search for Related Content PubMed PubMed Citation Articles by Harashima, N. Articles by Kannagi, M.

Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation

¹Department of Immunotherapeutics, Tokyo Medical and Dental University, Medical Research Division, Tokyo; ²Department of Hematology, Imamura Bun-in Hospital, Kagoshima; ³National Cancer Center Hospital, Tokyo; ⁴Second Department of Internal Medicine, University of the Ryukyus, Okinawa; and ⁵National Kyushu Cancer Center, Fukuoka, Japan

Adult T-cell leukemia (ATL) caused by human T-cell leukemia virus type I (HTLV-I) is characterized by poor prognosis after chemotherapy. Recent clinical trials have indicated, however, that allogeneic but not autologous hematopoietic stem cell transplantation (HSCT) for ATL can yield better clinical outcomes. In the present study, we investigated cellular immune responses of ATL patients who obtained complete remission after nonmyeloablative allogeneic peripheral blood HSCT from HLA-identical sibling donors. In the culture of peripheral blood mononuclear cells (PBMCs) from a post-HSCT but not pre-HSCT ATL patient, CD8⁺ CTLs proliferated vigorously in response to stimulation with autologous HTLV-I-infected T cells that had been established before HSCT in vitro. These CTLs contained a large number of monospecific CTL population directed to a HLA-A2-restricted HTLV-I Tax 11-19 epitope. The frequency of Tax 11-19-specific CD8+ CTLs in this patient markedly increased also in vivo after HSCT, as determined by staining with HLA-A2/Tax 11-19 tetramers. Similar clonal expansion of HTLV-I Tax-specific CTLs exclusively directed to a HLA-A24-restricted Tax 301-309 epitope was observed in the PBMCs from another ATL patient after HSCT from a HTLV-I-negative donor. Among four post-HSCT ATL patients tested, HTLV-I-specific CTLs were induced in the PBMC culture from three patients but not from the remaining one who had later recurrence of ATL. These observations suggested that reconstituted immunity against antigen presentation in ATL patients after HSCT resulted in strong and selective graft-versus-HTLV-I response, which might contribute to graft-versus-leukemia effects.

This article has been cited by other articles:

				K. Azakami, T. Sato, N. Araya, A. Utsunomiya, R. Kubota, K. Suzuki, D. Hasegawa, T. Izumi, H. Fujita, S. Aratani, et al. Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders Blood, October 8, 2009; 114(15): 3208 - 3215. [Abstract] [Full Text] [PDF]

				K. Suemori, H. Fujiwara, T. Ochi, T. Ogawa, M. Matsuoka, T. Matsumoto, J.-M. Mesnard, and M. Yasukawa HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes J. Gen. Virol., August 1, 2009; 90(8): 1806 - 1811. [Abstract] [Full Text] [PDF]

				S. Kinpara, A. Hasegawa, A. Utsunomiya, H. Nishitsuji, H. Furukawa, T. Masuda, and M. Kannagi Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I Interferon J. Virol., May 15, 2009; 83(10): 5101 - 5108. [Abstract] [Full Text] [PDF]

				T. Kozako, N. Arima, S. Toji, I. Masamoto, M. Akimoto, H. Hamada, X.-F. Che, H. Fujiwara, K. Matsushita, M. Tokunaga, et al. Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients J. Immunol., October 15, 2006; 177(8): 5718 - 5726. [Abstract] [Full Text] [PDF]

				H. Kobayashi, T. Ngato, K. Sato, N. Aoki, S. Kimura, Y. Tanaka, H. Aizawa, M. Tateno, and E. Celis In vitro Peptide Immunization of Target Tax Protein Human T-Cell Leukemia Virus Type 1-Specific CD4+ Helper T Lymphocytes. Clin. Cancer Res., June 15, 2006; 12(12): 3814 - 3822. [Abstract] [Full Text] [PDF]

				A. Mone, S. Puhalla, S. Whitman, R. A. Baiocchi, J. Cruz, T. Vukosavljevic, A. Banks, C. F. Eisenbeis, J. C. Byrd, M. A. Caligiuri, et al. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia Blood, November 15, 2005; 106(10): 3380 - 3382. [Abstract] [Full Text] [PDF]

				N. Harashima, R. Tanosaki, Y. Shimizu, K. Kurihara, T. Masuda, J. Okamura, and M. Kannagi Identification of Two New HLA-A*1101-Restricted Tax Epitopes Recognized by Cytotoxic T Lymphocytes in an Adult T-Cell Leukemia Patient after Hematopoietic Stem Cell Transplantation J. Virol., August 1, 2005; 79(15): 10088 - 10092. [Abstract] [Full Text] [PDF]

				M. Matsuoka and K.-T. Jeang Human T-Cell Leukemia Virus Type I at Age 25: A Progress Report Cancer Res., June 1, 2005; 65(11): 4467 - 4470. [Abstract] [Full Text] [PDF]

				J. Okamura, A. Utsunomiya, R. Tanosaki, N. Uike, S. Sonoda, M. Kannagi, M. Tomonaga, M. Harada, N. Kimura, M. Masuda, et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma Blood, May 15, 2005; 105(10): 4143 - 4145. [Abstract] [Full Text] [PDF]

				M. Kami, A. Makimoto, Y. Heike, and Y. Takaue Reduced-intensity Hematopoietic Stem Cell Transplantation (RIST) for Solid Malignancies Jpn. J. Clin. Oncol., December 1, 2004; 34(12): 707 - 716. [Abstract] [Full Text] [PDF]